Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Latest RNS from Convatec Group PLC
- board_changeCFO succession and NED appointment
- holdingsHolding(s) in Company
Analyst consensus: Buy
As of 21 Jul 2026, 18 analysts rate Convatec Group PLC a Buy, with 94% buy ratings and a mean price target of 297p (range 227p–369p), +36% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 307p against a current price of 215p (+42%), based on EV/EBITDA.